UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2023. or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17988 Neogen Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

Neogen Corporation (NASDAQ:NEOG) Q2 2024 Earnings Conference Call January 9, 2024 8:00 AM ET Company Participants John Adent - CEO Dave Naemura - CFO Bill Waelke - IR Conference Call Participants Brandon Vasquez - William Blair Operator Good day, and welcome to the Neogen Corporation Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now turn the conference over to Bill Waelke, Head of Inves ...

Disclaimer This presentation includes "forward-looking statements" as that term is defined in Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Neogen's current expectations and are subject to risks and uncertainties, which could cause actual results to differ from those stated or implied by such forward-looking statements. Should one or more of these risks or uncertainties materialize, or sho ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (State or other jurisdiction of incorporation or organization) Michigan 38-2367843 (IRS Employer Identification Number) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023. or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17988 N ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|-------|---------|---------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First | | Fiscal Year 2024 -Quarter | | | | | | | | | | | Results | | | | | | | | | | | | | October 10, 2023 | | Preliminary Results and Forward-Looking Statements This presentation includes "forward-looking statements" as that term is defined in Section 21E of the Se ...

Neogen Corporation (NASDAQ:NEOG) Q1 2024 Earnings Call Transcript October 10, 2023 8:00 AM ET Company Participants Bill Waelke - VP, Investor Relations John Adent - Chief Executive Officer David Naemura - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair Timothy Daley - Wells Fargo Operator Welcome to the Neogen Corporation First Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an op ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended May 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To . COMMISSION FILE NUMBER 0-17988 NEOGEN CORPORATION (Exact name of registrant as specified in its charter) (State of other jurisdiction of incorporation organization) MICHIGAN ...

Disclaimer Preliminary Results and Forward-Looking Statements This presentation includes "forward-looking statements" as that term is defined in Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Neogen's current expectations and are subject to risks and uncertainties, which could cause actual results to differ from those stated or implied by such forward-looking statements. Should one or more ...

Neogen Corporation (NASDAQ:NEOG) Q4 2023 Earnings Conference Call July 27, 2023 8:00 AM ET Company Participants Bill Waelke - Head, Investor Relations John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants Tim Daley - Wells Fargo Brandon Vazquez - William Blair David Westenberg - Piper Sandler Operator Good day. And welcome to the Neogen Corporation Fourth Quarter Fiscal Year 2023 Earnings Conference Call. All participants will be in listen-only mode. [Opera ...

For the quarterly period ended February 28, 2023. or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17988 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Neogen Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...